• Issue

    Transfusion: Volume 51, Issue 8

    1643-1876
    August 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

In this issue

In this issue

  • Page: 1643
  • First Published: 10 August 2011

EDITORIALS

Free Access

Does the storage duration of blood products affect outcomes in critically ill patients?

Philip C. Spinella,  Allan Doctor,  Neil Blumberg,  John B. Holcomb, 
  • Pages: 1644-1650
  • First Published: 10 August 2011
Free Access

A patient-centric approach to preventing allergic reactions to platelet transfusions

Eleftherios C. Vamvakas MD, PhD, 
  • Pages: 1651-1653
  • First Published: 10 August 2011
Free Access

Dengue: a potential transfusion-transmitted disease

Kay M. Tomashek,  Harold S. Margolis , 
  • Pages: 1654-1660
  • First Published: 10 August 2011

TRANSFUSION MEDICINE HISTORY ILLUSTRATED

An old-fashioned transfusion

Jean-Jacques Lefrère, 
  • Page: 1661
  • First Published: 10 August 2011

HOW DO I …?

How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations?

Anne F. Eder,  Mindy Goldman, 
  • Pages: 1662-1668
  • First Published: 10 March 2011

TRANSFUSION PRACTICE

Lack of effect of unrefrigerated young whole blood transfusion on patient outcomes after massive transfusion in a civilian setting

Kwok M. Ho,  Anton D. Leonard, 
  • Pages: 1669-1675
  • First Published: 22 December 2010

Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction

Aaron A.R. Tobian,  William J. Savage,  Daniel J. Tisch,  Sandra Thoman,  Karen E. King,  Paul M. Ness, 
  • Pages: 1676-1683
  • First Published: 07 January 2011

The appropriateness of red blood cell use and the extent of overtransfusion: right decision? Right amount?

Paul J. Barr,  Michael Donnelly,  Chris R. Cardwell,  Michael Parker,  Kieran Morris,  Karen E.M. Bailie, 
  • Pages: 1684-1694
  • First Published: 06 April 2011

A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients

Cristina Solomon,  Janne Cadamuro,  Bernhard Ziegler,  Herbert Schöchl,  Michael Varvenne,  Benny Sørensen,  Gerald Hochleitner,  Niels Rahe-Meyer, 
  • Pages: 1695-1706
  • First Published: 25 February 2011

Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study

Torben Pottgiesser,  Pierre-Edouard Sottas,  Tobias Echteler,  Neil Robinson,  Markus Umhau,  Yorck Olaf Schumacher, 
  • Pages: 1707-1715
  • First Published: 07 March 2011

TRANSFUSION COMPLICATIONS

Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes

William J. Savage,  Aaron A. Tobian,  Alice K. Fuller,  Robert A. Wood,  Karen E. King,  Paul M. Ness, 
  • Pages: 1716-1722
  • First Published: 07 January 2011

Modeling transfusion reactions and predicting in vivo cell survival with kodecytes

Caroline Oliver,  Deborah Blake,  Stephen Henry, 
  • Pages: 1723-1730
  • First Published: 08 February 2011

IMMUNOHEMATOLOGY

Continuing Medical Education Program in Transfusion

Anne F. Eder MD PhD, 
  • Page: 1731
  • First Published: 10 August 2011

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)

Michele LaSalle-Williams,  Rachelle Nuss,  Tuan Le,  Laura Cole,  Kathy Hassell,  James R. Murphy,  Daniel R. Ambruso, 
  • Pages: 1732-1739
  • First Published: 18 February 2011

Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors

Regina M. Leger,  George Garratty, 
  • Pages: 1740-1744
  • First Published: 08 February 2011

A new platelet alloantigen, Swia, located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia

Hartmut Kroll,  Korinna Feldmann,  Claudia Zwingel,  Jochen Hoch,  Rainer Bald,  Gregor Bein,  Behnaz Bayat,  Sentot Santoso, 
  • Pages: 1745-1754
  • First Published: 18 February 2011

TRANSPLANTATION AND CELLULAR ENGINEERING

Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow–derived cells with features of mesenchymal stem cells

Larisa Cervenakova,  Sergey Akimov,  Irina Vasilyeva,  Oksana Yakovleva,  Carroll McKenzie,  Juraj Cervenak,  Pedro Piccardo,  David M. Asher, 
  • Pages: 1755-1768
  • First Published: 08 February 2011

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation

Stéphanie Nguyen,  Vivien Béziat,  Françoise Norol,  Madalina Uzunov,  Hélène Trebeden-Negre,  Nabih Azar,  Ali Boudifa,  Dominique Bories,  Patrice Debré,  Jean-Paul Vernant,  Vincent Vieillard,  Nathalie Dhédin, 
  • Pages: 1769-1778
  • First Published: 18 February 2011

A randomized clinical trial comparing granulocyte–colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation

Heather Renfroe,  Mike Arnold,  Louette Vaughn,  R. Donald Harvey,  Ellie Hamilton,  Sagar Lonial,  H. Jean Khoury,  Jonathan L. Kaufman,  Mary Jo Lechowicz,  Christopher R. Flowers,  Edmund K. Waller, 
  • Pages: 1779-1783
  • First Published: 18 February 2011

The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels

Lina Paola D'Atri,  Julia Etulain,  María Albertina Romaniuk,  Oscar Torres,  Soledad Negrotto,  Mirta Schattner, 
  • Pages: 1784-1795
  • First Published: 18 February 2011

BLOOD DONORS AND BLOOD COLLECTION

Enhancing blood donation intentions using multimedia donor education materials

Christopher R. France,  Janis L. France,  Mary Ellen Wissel,  Jennifer M. Kowalsky,  Elizabeth M. Bolinger,  Jamie L. Huckins, 
  • Pages: 1796-1801
  • First Published: 08 February 2011

Effect of applied muscle tension on cerebral oxygenation in female blood donors

Jennifer M. Kowalsky,  Janis L. France,  Mary Ellen Wissel,  Christopher R. France, 
  • Pages: 1802-1808
  • First Published: 07 March 2011

Barriers to blood donation in African communities in Australia: the role of home and host country culture and experience

Michael Jay Polonsky,  André M.N. Renzaho,  Bianca Brijnath, 
  • Pages: 1809-1819
  • First Published: 18 February 2011

Healthy donor effect: its magnitude in health research among blood donors

Femke Atsma,  Ingrid Veldhuizen,  André Verbeek,  Wim de Kort,  Femmie de Vegt, 
  • Pages: 1820-1828
  • First Published: 22 February 2011

Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior

Mindy Goldman,  Qi-Long Yi,  Xibiao Ye,  Lorna Tessier,  Sheila F. O'Brien, 
  • Pages: 1829-1834
  • First Published: 07 March 2011

BLOOD COMPONENTS

Effect on the quality of blood components after simulated blood transfusions using volumetric infusion pumps

Ryanne W. Lieshout-Krikke,  Pieter F. van der Meer,  Maria M.W. Koopman,  Dirk de Korte, 
  • Pages: 1835-1839
  • First Published: 08 February 2011

DONOR INFECTIOUS DISEASE TESTING

Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors

Dong Hee Seo,  Dong Hee Whang,  Eun Young Song,  Hyun Soo Kim,  Quehn Park, 
  • Pages: 1840-1846
  • First Published: 18 February 2011

COMMENTARY

Pitfalls in the current published observational literature on the effects of red blood cell storage

Leo van de Watering,  for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative , 
  • Pages: 1847-1854
  • First Published: 14 January 2011

CONFERENCE REPORT

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety

Chintamani Atreya,  Hira Nakhasi,  Paul Mied,  Jay Epstein,  James Hughes,  Marta Gwinn,  Steven Kleinman,  Roger Dodd,  Susan Stramer,  Mark Walderhaug,  Peter Ganz,  Raymond Goodrich,  Clark Tibbetts,  David Asher, 
  • Pages: 1855-1871
  • First Published: 10 March 2011

LETTERS TO THE EDITOR

Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom

Anna M. Molesworth PhD,  Jan Mackenzie,  Dawn Everington MSc,  Richard S.G. Knight FRCPE,  Robert G. Will FRCP, 
  • Pages: 1872-1873
  • First Published: 10 August 2011

In reply

Maria Puopolo DStat,  Anna Ladogana MD,  Vito Vetrugno PhD,  Maurizio Pocchiari MD, 
  • Pages: 1873-1874
  • First Published: 10 August 2011

ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants

Fouad N. Boctor MD, PhD,  Madhu BhasKaran MD,  Bridget Sheahan BS,  W.A. Heaton MD,  Ernesto Molmenti MD, 
  • Pages: 1874-1875
  • First Published: 10 August 2011

Conditions for plasma processing

Albert Farrugia PhD,  Chris V. Prowse MA, DPhil, FRCPathol, SRCS,  Valerie Scott Hornsey PhD, 
  • Pages: 1875-1876
  • First Published: 10 August 2011

In reply

Rebecca Cardigan PhD, FRCPath, 
  • Page: 1876
  • First Published: 10 August 2011